This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Initiator Pharma Management
Management criteria checks 2/4
Key information
Claus Olesen
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 6.2yrs |
CEO ownership | 2.1% |
Management average tenure | 6.3yrs |
Board average tenure | 5.8yrs |
Recent management updates
No updates
Recent updates
CEO
Claus Olesen (48 yo)
6.2yrs
Tenure
Dr. Claus Elsborg Olesen is Chief Executive Officer at Stipe Therapeutics. He serves Chief Executive Officer at Initiator Pharma A/S since May 02, 2016 and serves as its Director since September 19, 2016 a...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 6.2yrs | no data | 2.08% SEK 7.3m | |
Co-Founder & CTO | 6.5yrs | no data | 2.54% SEK 8.9m | |
Co-Founder | no data | no data | 1.28% SEK 4.5m | |
Co-Founder & CDO | no data | no data | 1.41% SEK 4.9m | |
Chief Financial Officer | 6.5yrs | no data | 0.60% SEK 2.1m | |
Senior Vice President of Clinical and R&D Strategy & Portfolio Management | 1.6yrs | no data | no data | |
Head of Clin Ops | no data | no data | no data | |
Head of CMC | no data | no data | no data |
6.3yrs
Average Tenure
58yo
Average Age
Experienced Management: INIT BTA's management team is seasoned and experienced (6.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 5.8yrs | no data | 2.08% SEK 7.3m | |
Chairman of the Board of Directors | 5.8yrs | no data | 0.52% SEK 1.8m | |
Director | 5.8yrs | no data | 0.24% SEK 844.9k | |
Member of Scientific & Clinical Advisory Board | 1.6yrs | no data | no data | |
Director | 1.5yrs | no data | 0.015% SEK 52.3k | |
Director | 5.8yrs | no data | no data | |
Member of Scientific & Clinical Advisory Board | 1.6yrs | no data | no data |
5.8yrs
Average Tenure
57yo
Average Age
Experienced Board: INIT BTA's board of directors are considered experienced (5.8 years average tenure).